Clinical Trials Directory

Trials / Unknown

UnknownNCT04917003

Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease

Safety and Efficacy of Remote Ischemic Conditioning Combined Encephaloduroarteriosynangiosis(EDAS)on Ischemic Moyamoya Disease: A Prospective, Randomized, Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Encephaloduroarteriosynangiosis (EDAS) is widely used as an indirect technique for treatment of moyamoya disease. Nevertheless, this indirect surgery tends to establish insufficient collateral circulation in most adult MMD patients. Nowadays, there is a lack of adjuvant therapies for improving collateral circulation induced by indirect revascularization. This study aims to explore whether remote ischemic conditioning can improve the collateral circulation after indirect revascularization.

Detailed description

Encephaloduroarteriosynangiosis (EDAS) is widely used as an indirect technique for treatment of moyamoya disease. Nevertheless, this indirect surgery tends to establish insufficient collateral circulation in most adult MMD patients. Nowadays, there is a lack of adjuvant therapies for improving collateral circulation induced by indirect revascularization. Remote ischemic conditioning (RIC) is a noninvasive approach protecting the brain by inflating and deflating blood-pressure cuff placed on the upper limbs. It has been confirmed to improve cerebral perfusion by promoting angiogenesis and arteriogenesis in ischemic animal brain. In addition, daily remote ischemic conditioning is a promising technique to ameliorate chronic cerebrovascular disease like intracranial atherosclerotic stenosis, small-vessel disease. Thus, this study aims to explore whether remote ischemic conditioning can improve the collateral circulation after indirect revascularization.

Conditions

Interventions

TypeNameDescription
OTHERRIC plus EDASPatients who are allocated into RIC group will undergo EDAS surgery combined 3-month RIC treatment. The opposite operation will be performed at 3 months after the first operation.
OTHEREDASPatients who are allocated into the control group will accept EDAS surgery twice. The second operation will be performed at 3 months after the first operation.

Timeline

Start date
2021-06-15
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2021-06-08
Last updated
2021-06-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04917003. Inclusion in this directory is not an endorsement.